Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,350 | -12,018 | -53,689 | -39,561 | -26,999 |
| Depreciation Amortization | 1,156 | 583 | 2,390 | 1,784 | 1,187 |
| Accounts receivable | -2,158 | -581 | -3,079 | -4,061 | -4,004 |
| Accounts payable and accrued liabilities | -1,246 | 368 | 1,279 | -432 | -1,840 |
| Other Working Capital | -6,846 | -3,201 | -3,251 | -8,691 | -8,816 |
| Other Operating Activity | 4,709 | 1,005 | 4,928 | 6,831 | 7,488 |
| Operating Cash Flow | $-29,735 | $-13,844 | $-51,422 | $-44,130 | $-32,984 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -153 | -153 | -976 | -927 | -567 |
| Net Acquisitions | N/A | N/A | 65 | 65 | 65 |
| Purchase Of Investment | N/A | N/A | -16,535 | -16,534 | -16,534 |
| Sale Of Investment | N/A | N/A | 90,243 | 81,152 | 52,843 |
| Investing Cash Flow | $-153 | $-153 | $72,797 | $63,756 | $35,807 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 20,318 | 20,410 | 623 | 572 | -243 |
| Other Financing Activity | -58 | -37 | -1,410 | -1,398 | 0 |
| Financing Cash Flow | $20,260 | $20,373 | $-787 | $-826 | $-243 |
| Beginning Cash Position | 38,083 | 38,083 | 17,495 | 17,495 | 17,495 |
| End Cash Position | 28,455 | 44,459 | 38,083 | 36,295 | 20,075 |
| Net Cash Flow | $-9,628 | $6,376 | $20,588 | $18,800 | $2,580 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,735 | -13,844 | -51,422 | -44,130 | -32,984 |
| Capital Expenditure | -153 | -153 | -976 | -927 | -567 |
| Free Cash Flow | -29,888 | -13,997 | -52,398 | -45,057 | -33,551 |